Meanwhile, the cancer immunotherapy sector reached $137.70 billion in 2024 and is projected to hit $261.74 billion by 2033 as major pharmaceutical companies unveiled breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback